Momenta Pharmaceuticals, Inc. (MNTA)

[urche]

Having held shares since 2007 (and gone silent years ago when I got disenchanted with all the legal wranglings) it is time to reevaluate holding MNTA. I had always assumed that after copaxone approval there would be a nice pop and a good time to sell some or all of my position.
But, once again, the case for holding seems, if anything even more compelling. I agree with Tony, Flo,and others that MNTA still is a good value. Even more attractive to me is that, after years of tenuously clinging to a high risk hope, this stock is a lot less risky now.

Urche

PS: Great to see Old Berk still lurking